Abstract: Systems and methods are disclosed for calculating and utilizing a variable CPU weighting factor for host configuration optimization in a data center environment. According to one illustrative embodiment, implementations may utilize actual workload profiles to generate variable CPU weighting factor(s) to optimize host configurations.

Abstract: The present invention relates to nutritional supplements to be administered to, or to be taken by, people who are subject, or thought to be subject to, iron deficiency anemia. The nutritional supplements of this invention have a unique formulation of iron and folic acid-related materials in addition to certain other vitamins and minerals and a nutritionally acceptable carrier therefor. The invention describes specific nutritional supplements for the use set forth above.

Abstract: In one embodiment, a system includes a face plate, an electrical contact, and a support structure interfacing to the face plate and supporting the electrical contact, wherein the electrical contact is repositionable with respect to the face plate along two distinct axes.

Abstract: Described herein are manufactured dietary supplements that contain a phospholipid extract, folic acid, vitamin D, vitamin B6, vitamin B12, Vitamin E, Vitamin C, iodine, iron, and magnesium. Described herein are manufactured dietary supplements that contain a phospholipid extract that contain phospholipid-DHA.

Abstract: In one example, an active cover plate includes a faceplate, a load and a spring clip adjustable in at least one of a horizontal direction and a vertical direction with respect to the faceplate to electrically interface with a receptacle body and extract electrical power from the receptacle body to energize the load. A method for installing an active cover plate on an electrical receptacle is also provided.

Abstract: Described is a technology by which machines of a (typically small) network have associated public key-based certificates for use in authentication with a server and validation of other machines in the network. This provides an inexpensive and straightforward mechanism to control, manage and maintain client machines, as well as to allow valid client machines to securely communicate with one another and recognize machines that are not valid on the network. Certificates are maintained on the server and checked for validity as needed.

Abstract: Described herein are manufactured dietary supplements that contain a phospholipid extract and the extract contains two forms of phospholipid-docosahexanoic acid. One form of phospholipid-docosahexanoic acid is phosphatidylcholine-docosahexanoic acid, and another form of phospholipid-docosahexanoic acid is phosphatidylethanolamine-docosahexanoic acid.

Abstract: Described herein are manufactured dietary supplements that contain a phospholipid extract derived from eggs, where the extract contains phospholipid-docosahexaenoic acid derived from eggs, folate, vitamin D, vitamin B6, vitamin B12, vitamin C, calcium, iron, N-Acetyl-L-Cysteine, iodine, and magnesium. Described herein are manufactured dietary supplements that contain a phospholipid extract derived from eggs and the extract contains two forms of phospholipid-docosahexaenoic acid derived from eggs. One form of phospholipid-docosahexaenoic acid is phosphatidylcholine-docosahexaenoic acid, and another form of phospholipid-docosahexaenoic acid is phosphatidylethanolamine-docosahexaenoic acid. And the phospholipid extract has less than about 3% by weight of free triglycerides.

Abstract: Described herein are manufactured dietary supplements that contain a phospholipid extract and the extract contains two forms of phospholipid-docosahexanoic acid. One form of phospholipid-docosahexanoic acid is phosphatidylcholine-docosahexanoic acid, and another form of phospholipid-docosahexanoic acid is phosphatidylethanolamine-docosahexanoic acid. The manufactured dietary supplement also contains L-methylfolate, vitamin B6, and vitamin B12.

Abstract: Described herein are manufactured dietary supplements that contain a phospholipid extract and the extract contains two forms of phospholipid-docosahexanoic acid. One form of phospholipid-docosahexanoic acid is phosphatidylcholine-docosahexanoic acid, and another form of phospholipid-docosahexanoic acid is phosphatidylethanolamine-docosahexanoic acid. The manufactured dietary supplement also contains L-methylfolate, vitamin B6, and vitamin B12.

Abstract: Described herein are manufactured dietary supplements that contain a phospholipid extract and the extract contains two forms of phospholipid-docosahexanoic acid. One form of phospholipid-docosahexanoic acid is phosphatidylcholine-docosahexanoic acid, and another form of phospholipid-docosahexanoic acid is phosphatidylethanolamine-docosahexanoic acid. The manufactured dietary supplement also contains L-methylfolate.

Abstract: A nutritional supplement for a human, the supplement having a chelate comprised of an N-acetyl-L-cysteine ligand bonded to zinc to form a chelate ring. A method of treating a human for one or more of oxidative stress, cardiovascular disease, cerebrovascular disease, neurodegenerative diseases, Alzheimer's disease, ADHD, bipolar, schizophrenia, autism, dementia, and HIV in a human comprising administering an effective amount of a composition having N-acetyl-L-cysteine in a chelate formation with zinc. A compound having a chelate formulation with zinc being chelated by an N-acetyl-L-cysteine ligand.

Abstract: Described herein are manufactured dietary supplements that contain a phospholipid extract and the extract contains two forms of phospholipid-docosahexanoic acid. One form of phospholipid-docosahexanoic acid is phosphatidylcholine-docosahexanoic acid, and another form of phospholipid-docosahexanoic acid is phosphatidylethanolamine-docosahexanoic acid.

Abstract: Described herein are manufactured dietary supplements that contain a phospholipid extract derived from eggs, where the extract contains phospholipid-docosahexanoic acid derived from eggs, folate, vitamin D, vitamin B6, vitamin B12, vitamin C, calcium, iron, N-Acytl-L-Cysteine, iodine, and magnesium. Described herein are manufactured dietary supplements that contain a phospholipid extract derived from eggs and the extract contains two forms of phospholipid-docosahexanoic acid derived from eggs. One form of phospholipid-docosahexanoic acid is phosphatidylcholine-docosahexanoic acid, and another form of phospholipid-docosahexanoic acid is phosphatidylethanolamine-docosahexanoic acid. And the phopholipid extract has less than about 3% by weight of free triglycerides.

Abstract: A nutritional supplement for a human, the supplement having a chelate comprised of an N-acetyl-L-cysteine ligand bonded to a metal to form a chelate ring. A method for preparing a chelate comprised of N-acetyl-L-cysteine ligand and a metal having the steps of: dissolving an amount of N-acetyl-L-cysteine in an aqueous solution, adding a metal to the aqueous solution, stifling and heating the aqueous solution, and removing the solvent under reduced pressure. A method of treating a human for one or more of oxidative stress, cardiovascular disease, cerebrovascular disease, neurodegenerative diseases, Alzheimer's disease, ADHD, bipolar, schizophrenia, autism, dementia, and HIV in a human comprising administering an effective amount of a composition having N-acetyl-L-cysteine in a chelate formation with a metal. A compound having a chelate formulation with a metal being chelated by an N-acetyl-L-cysteine ligand.

Abstract: A nutritional supplement that contains folinic acid, folic acid, USP, methylfolic acid, cobalamin, magnesium, docosahexaenoic acid, phosphatidylcholine-docosahexaenoic acid, phosphatidylethanolamine-docosahexaenoic acid. A nutritional supplement is disclosed for the treatment of cognitive disorders, attention deficit disorder, oxidative stress, depression, memory loss, anxiety, and apathy.

Abstract: A composition made of folic acid and at least one citrate buffer, wherein the ratio of folic acid to citrate buffer is from 1:2 to 1:5. A nutritional supplement having a composition made of folic acid, and at least one citrate buffer, wherein the ratio of folic acid to citrate buffer is from 1:2 to 1:5, and a coating. A method of delivering folic acid to a patient according to USP, having the step of administering to a patient a composition comprising a folic acid, and at least one citrate buffer, wherein the ratio of folic acid to citrate buffer is from 1:2 to 1:5, and a coating.

Abstract: In one example, an active cover plate includes a faceplate, a load and a spring clip adjustable in at least one of a horizontal direction and a vertical direction with respect to the faceplate to electrically interface with a receptacle body and extract electrical power from the receptacle body to energize the load. A method for installing an active cover plate on an electrical receptacle is also provided.

Abstract: A nutritional supplement for a human, the supplement having a chelate comprised of an N-acetyl-L-cysteine ligand bonded to a metal to form a chelate ring. A method for preparing a chelate comprised of N-acetyl-L-cysteine ligand and a metal having the steps of: dissolving an amount of N-acetyl-L-cysteine in an aqueous solution, adding a metal to the aqueous solution, stifling and heating the aqueous solution, and removing the solvent under reduced pressure. A method of treating a human for one or more of oxidative stress, cardiovascular disease, cerebrovascular disease, neurodegenerative diseases, Alzheimer's disease, ADHD, bipolar, schizophrenia, autism, dementia, and HIV in a human comprising administering an effective amount of a composition having N-acetyl-L-cysteine in a chelate formation with a metal. A compound having a chelate formulation with a metal being chelated by an N-acetyl-L-cysteine ligand.

Abstract: A system for adding value to a host device via a mobile communication device is described. The system includes: a host device configured for providing additional value to be utilized, wherein the additional value includes at least one printing device function and is provided in response to receiving an authentication code; a central system configured for providing the authentication code for inputting into the host device to authorize the at least one printing device function to be utilized; and a mobile communication device configured for negotiating the additional value to be applied to the host device.